医学
糖尿病
丙型肝炎
危险系数
内科学
丙型肝炎病毒
体质指数
相对风险
置信区间
风险因素
免疫学
内分泌学
病毒
作者
Andrea A. Howard,Donald R. Hoover,Kathryn Anastos,Xi Wu,Qiuhu Shi,Howard D. Strickler,Stephen R. Cole,Mardge H. Cohen,Andrea Kovacs,Michael Augenbraun,Patricia S. Latham,Phyllis C. Tien
标识
DOI:10.1097/qai.0b013e3181d0c911
摘要
Opiate use is common in HIV-infected and hepatitis C virus (HCV)-infected individuals, however, its contribution to the risk of diabetes mellitus is not well understood.Prospective study of 1713 HIV-infected and 652 HIV-uninfected participants from the Women's Interagency HIV Study between October 2000 and March 2006. Diabetes defined as fasting glucose > or =126 mg/dL, self report of diabetes medication use, or confirmed diabetes diagnosis. Opiate use determined using an interviewer-administered questionnaire. Detectable plasma HCV RNA confirmed HCV infection.Current opiate users had a higher prevalence of diabetes (15%) than nonusers (10%, P = 0.03), and a higher risk of incident diabetes (adjusted relative hazard: 1.58, 95% confidence interval: 1.01 to 2.46), after controlling for HCV infection, HIV/antiretroviral therapy status, and diabetes risk factors including age, race/ethnicity, family history of diabetes, and body mass index. HCV infection was also an independent risk factor for diabetes (adjusted relative hazard: 1.61, 95% confidence interval: 1.02 to 2.52). HCV-infected women reporting current opiate use had the highest diabetes incidence (4.83 cases per 100 person-years).Among women with or at-risk for HIV, opiate use is associated with increased diabetes risk independently of HCV infection. Diabetic screening should be part of care for opiate users and those infected with HCV.
科研通智能强力驱动
Strongly Powered by AbleSci AI